Inhaled insulin proves effective in new study

The inhaled insulin, a promise for decades, has proven effective in the first large-scale study for the treatment of type 1 diabetes. The Food and Drug Administration is analyzing the results to determine whether it is safe and effective enough to approve its use.
The decision should come by year's end, said Dr. Jay Skyler, associate director of the Diabetes Research Institute at the University of Miami. Skyler led the study, which appears in the July issue of Diabetes Care, a research journal published by the American Diabetes Association.
Patients would still require a daily injectable dose of insulin, but the inhaled form could be used before meals to balance the diabetic's insulin levels, Skyler said.
"I like it much better than injections,"